Neuranix

NEURANIX, a health care startup founded in 2020 in Italy, is making waves in audiology diagnostics with its innovative approach and cutting-edge technology. The company has developed and patented medical devices for both humans and pets, with a specific focus on audiological solutions. Collaborating with experts and institutions such as CNR and leading universities, NEURANIX has successfully launched two products: Vet-Wave for the veterinary market and Med-Wave for human use, which is set to be introduced in mid-2023. The startup recently secured a notable €2.10M in a Venture Round investment on 01 June 2022, with backing from prominent investors, CDP Equity and CDP Venture Capital. NEURANIX’s commitment to transforming audiology diagnostics positions it as a promising player in the health care industry, poised for significant growth and impact. For further details, reach out to [email protected].